NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2016 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Navidea Biopharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2016 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 99.4M shares, a 223% increase year-over-year.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 30.9M shares, a 5.31% increase from 2021.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29.3M shares.
  • Navidea Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2018 was 171M shares, a 5.53% increase from 2017.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 99.4M +68.6M +223% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 48.2M +18M +59.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 32.7M +2.45M +8.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 30.9M +1.56M +5.31% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 30.7M +609K +2.02% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 30.3M +1.15M +3.95% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 30.2M +2.14M +7.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 29.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 30.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 29.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 28.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2019 10M +1.9M +23.5% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 171M +8.94M +5.53% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-15
Q3 2018 167M +4.85M +2.99% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-09
Q2 2018 163M +806K +0.5% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-08
Q1 2018 8.11M -152M -94.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 162M +6.17M +3.97% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 162M +6.53M +4.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 162M +6.53M +4.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 160M +5.07M +3.26% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 155M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 155M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 155M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 155M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.